| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $810K | — | -38.4% |
| SG&A Expense | $1.5M | — | +32.2% |
| Operating Income | -$2.3M | — | +6.3% |
| Interest Expense | $17K | — | -83.0% |
| Net Income | -$2.2M | — | +1.9% |
| EPS (Basic) | -$0.05 | — | +37.5% |
| EPS (Diluted) | -$0.05 | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.4M | -10.9% | +637.4% |
| Current Assets | $10.5M | -11.9% | +436.8% |
| Total Assets | $10.7M | -11.9% | +333.6% |
| Total Liabilities | $964K | +97.6% | +69.3% |
| Stockholders' Equity | $9.7M | -16.5% | +412.8% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.3M | — | +24.7% |
| +37.5% |